
THE NEW STANDARD
THE FIRST AND ONLY MULTIMODAL MRD PLATFORM FOR ALL SOLID TUMORS.*
Be the first to know more about Guardant Reveal Ultra.
SIGN UP NOW Powerful on their own.
Together, something greater.
Guardant Reveal Ultra unites the #1 tissue-free MRD test with
a tissue-informed approach in a single workflow.†

FAST, ULTRA-SENSITIVE
MRD INSIGHTS‡§

EARLY CLINICAL SIGNAL
IN 7 DAYS1‡
DETECTION DOWN
TO 1 PPM2§


Guardant Reveal Ultra brings the
most advanced multiomic view to MRD.*
Capturing up to 5x more molecular signals than a single-modality approach.¶
ctDNA, circulating tumor DNA; MRD, minimal or molecular residual disease; PPM, parts per million.
*Based on publicly available information. “First and only” and “most advanced” refer to the first and only commercially available platform that integrates epigenomic insights from a tissue-free approach and genomic insights from a tissue-informed approach across all solid tumors in one MRD report.
†Based on ctDNA test share from the MRD in early-stage cancer patient chart audit. Guardant Health data on file. April 2026.
‡Most tissue-free results are delivered in 7 days (median turnaround time from sample receipt to results).
§Tissue-informed detection is down to 1 ppm for certain cancer types.
¶Comparison of Guardant Reveal Tissue-Informed, a single-modality approach, with Guardant Reveal Ultra, based on the number of epigenomic and genomic signals evaluated.
References: 1. Guardant Reveal Tissue-Free Assay Specifications. 2026. Guardant Health, Inc. Redwood City, CA. 2. Guardant Reveal Tissue-Informed Assay Specifications. 2026. Guardant Health, Inc. Redwood City, CA.
Important note: Guardant Reveal Tissue-Free and Guardant Reveal Tissue-Informed were developed as Laboratory Developed Tests (LDTs), and their performance characteristics determined, by the Guardant Health Clinical Laboratory in Redwood City, CA, USA, which is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical testing. These tests have not been cleared or approved by the US FDA.
InfinityAI is not a standalone customer product. “Powered by InfinityAI” refers to Guardant Health artificial intelligence and machine learning technology used in development of product features. These features are reported as professional service and have not been cleared or approved by the US FDA.